Westpac Banking Corp cut its position in IMS Health Holdings Inc. (NYSE:IMS) by 32.5% during the second quarter, Holdings Channel reports. The firm owned 9,448 shares of the company’s stock after selling 4,557 shares during the period. Westpac Banking Corp’s holdings in IMS Health Holdings were worth $240,000 at the end of the most recent quarter.
Several other institutional investors also recently made changes to their positions in IMS. Goldman Sachs Group Inc. boosted its position in shares of IMS Health Holdings by 493.8% in the first quarter. Goldman Sachs Group Inc. now owns 912,774 shares of the company’s stock worth $24,234,000 after buying an additional 759,060 shares during the period. Pictet Asset Management Ltd. raised its stake in shares of IMS Health Holdings by 1.4% in the first quarter. Pictet Asset Management Ltd. now owns 57,700 shares of the company’s stock worth $1,488,000 after buying an additional 800 shares in the last quarter. UBS Asset Management Americas Inc. raised its stake in shares of IMS Health Holdings by 6.4% in the first quarter. UBS Asset Management Americas Inc. now owns 319,730 shares of the company’s stock worth $8,489,000 after buying an additional 19,316 shares in the last quarter. UBS Group AG raised its stake in shares of IMS Health Holdings by 16.7% in the first quarter. UBS Group AG now owns 37,287 shares of the company’s stock worth $990,000 after buying an additional 5,327 shares in the last quarter. Finally, State Street Corp raised its stake in shares of IMS Health Holdings by 10.6% in the first quarter. State Street Corp now owns 2,510,299 shares of the company’s stock worth $66,649,000 after buying an additional 241,422 shares in the last quarter. Hedge funds and other institutional investors own 90.25% of the company’s stock.
Shares of IMS Health Holdings Inc. (NYSE:IMS) opened at 31.34 on Friday. IMS Health Holdings Inc. has a 12 month low of $22.36 and a 12 month high of $31.59. The company has a market capitalization of $10.32 billion, a price-to-earnings ratio of 76.07 and a beta of 0.83. The firm’s 50-day moving average price is $30.07 and its 200-day moving average price is $27.50.
IMS Health Holdings (NYSE:IMS) last issued its quarterly earnings data on Wednesday, July 27th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. IMS Health Holdings had a return on equity of 30.61% and a net margin of 4.45%. The business had revenue of $802 million for the quarter, compared to analysts’ expectations of $796.93 million. During the same period last year, the business earned $0.37 EPS. The business’s revenue was up 112.4% on a year-over-year basis. Equities research analysts expect that IMS Health Holdings Inc. will post $1.62 EPS for the current year.
A number of equities research analysts recently issued reports on the company. TheStreet lowered IMS Health Holdings from a “buy” rating to a “hold” rating in a research note on Monday, August 29th. Zacks Investment Research raised IMS Health Holdings from a “sell” rating to a “hold” rating and set a $34.00 price target for the company in a research note on Friday, July 29th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $31.00.
About IMS Health Holdings
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Want to see what other hedge funds are holding IMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMS Health Holdings Inc. (NYSE:IMS).
Receive News & Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.